期刊文献+

阿托伐他汀对急性脑梗死患者血清hs—CRP、IL-6、IL-10及神经功能缺损的影响 被引量:6

Effect of atorvastatin on the level of serum hs - CRP, IL - 6, IL - 10 and neurological deficits in patients with acute cerebral infarction
原文传递
导出
摘要 目的观察阿托伐他汀对急性脑梗死(ACI)患者血清超敏c-反应蛋白(hs—CRP)、白细胞介素-6(IL-6)、白细胞介素-10(IL-10)以及神经功能缺损的影响,探讨其抗炎作用机制。方法将90例ACI患者随机分为阿托伐他汀组45例和常规治疗组45例。阿托伐他汀组在常规治疗基础上加用阿托伐他汀20mg,每日1次,连服4周。治疗前后检测血清hs—CRP、IL-6和IL-10含量,并进行神经功能缺损程度评分(NDS)评定。另选同期健康查体正常者20例为正常对照组。结果ACI患者较健康对照组血清hs—CRP、IL-6显著升高,IL-10显著下降(P〈0.05);两组ACI患者治疗前hs—CRP、IL-6和IL-10差异无统计学意义(P〉0.05),治疗4周后阿托伐他汀组hs—CRP、IL-6较常规治疗组明显下降,而IL-10明显升高(P〈0.05)。此外,阿托伐他汀组治疗后NDS评分较常规治疗组显著升高(P〈0.05)。结论ACI患者较健康者血清hs—CRP、IL-6水平升高,IL—10水平下降。阿托伐他汀能明显降低ACI患者血清hs—CRP、IL-6水平,升高血清IL—10水平,有助于ACI患者的神经功能恢复,具有减轻炎症反应的神经保护作用。 Objective To study the effect of atorvastatin on the level of serum high -sensitivity C - reactive protein (hs - CRP), interleukin - 6 ( IL - 6 ), interleukin - 10 ( IL - 10) and neurological deficits in patients with acute cerebral infartion (ACI). Methods Ninety patients with ACI were randomly divided into the atorvastatin therapy group( n =45 ) and the conventional therapy group (n = 45 ). At the basic of conventional therapy, the atorvastatin therapy group was treated with atorvastatin 20 mg/d. Both groups were treated for 4 weeks. The levels of serum hs - CRP, IL - 6 and IL - 10 were measured and the scores of neurological deficit scores (NDS) were evaluated before and after treatment. A healthy control group which approximately matched the experimental group included 20 heahy people. Results The level of serum hs- CRP, IL-6 in ACI patients was higher than that in the control groups, IL- 10 in ACI patients was lower than that in the control groups( P 〈0.05 ). No difference of hs - CRP, IL -6 or IL - 10 was found between the atorvastatin groups and the control groups before treatment ( P 〉 0.05). But the level of hs - CRP and IL - 6 in atorvastatin groups decreased after treatment compared with control groups (P 〈 0.05). While the IL -10 in atorvastatin group increased after treatment ( P 〈0.05). The NDS in atorvastatin groups increased after treatment compared with control groups ( P 〈 0.05). Conclusions Atorvastatin can significantly decrease the level of serum hs - CRP and IL -6, and increase the level of serum IL - 10. It can promote the neurological fuction recovery in patients with ACI. Atorvastatin may have anti -inflammatory effects and neuroprotection role.
出处 《中国实用医刊》 2011年第2期25-26,29,共3页 Chinese Journal of Practical Medicine
关键词 阿托伐他汀 脑梗死 急性 超敏C-反应蛋白 白细胞介素-6 白细胞介素-10 神经功能缺损程度评分 Atorvastatin Acute cerebral infarction High -sensitivity C -reactive protein Interleukin - 6 Interleukin - 10 Neurological deficit scores
  • 相关文献

同被引文献77

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部